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Introduction: Streptococcus agalactiae or group B streptococcus is a Gram-positive pathogen that is typically
associated with neonatal disease and infection in pregnant women. Group B streptococcus also causes invasive
infections in non-pregnant adults including urinary tract infections. The spectrum of urinary tract infections caused
by group B streptococcus includes cystitis, pyelonephritis, urosepsis and asymptomatic bacteriuria, which is
particularly common among elderly individuals. A rare form of invasive group B streptococcus infection in adults is
secondary abscess. Here, we present the first reported case of a patient who developed an unusual, massive
abdominopelvic abscess secondary to acute group B streptococcus urinary tract infection.
Case presentation: A 46-year-old African-American woman presented to the University Emergency Department
complaining of urinary tract infection symptoms and severe abdominal pain. Diagnostic imaging by transvaginal
ultrasound and computed tomography revealed a massive peripherally-enhancing, low-attenuating fluid collection
within her pelvis. The patient’s abdominopelvic abscess was drained by ultrasound-guided drainage and this
yielded a septic aspirate that was culture positive for abundant S. agalactiae. A recent history of urinary tract
infection symptoms in the patient suggested that her abscess developed secondary to cystitis. Complete resolution
of the abscess as a favorable outcome was achieved in this case following surgical drainage and appropriate
antimicrobial therapy.
Conclusion: Acute bacterial urinary tract infection leading to an abdominopelvic abscess has not previously been
reported in the literature. This case report defines a new disease etiology associated with acute streptococcal
cystitis and it will be of interest in cases of urinary tract infections where there is an association with abdominal
and/or pelvic pain. A brief review of the literature on unusual secondary abscesses due to group B streptococcus is
provided alongside this case to highlight the clinical significance and prognoses of these rare infections. Finally, this
case emphasizes the requirement to distinguish unusual etiologies of pyogenic abscesses in order to guide
successful clinical management and to treat patients with antibiotics active against the causal organism.
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Streptococcus agalactiae, or group B streptococcus
(GBS), is a leading cause of infection in newborns, preg-
nant women, and older persons with chronic medical ill-
ness [1]. In addition to maternal cervicovaginal
colonization and neonatal infection, GBS causes invasive
infections in adults including urinary tract infections
(UTI). The incidence of neonatal disease has decreased
due to improvements in screening and prophylaxis [1-3],
and the changing spectrum of disease in adults has been
noted [4]. Over 60% of cases of invasive GBS disease in
the United States of America (USA) now occur in adults
and most are unrelated to pregnancy [5]. A rare form of
invasive GBS infection in adults is secondary abscess,
which characteristically presents as a subcutaneous,
retroperitoneal psoas, thoracic, aortic, or myocardial ab-
scess secondary to an often-occult source of infection.
GBS is a notable urinary pathogen in adults [6] and
reports on the incidence of genitourinary infections due
to GBS have increased in the past decade [4,7-11]. The
spectrum of GBS UTI includes asymptomatic bacteri-
uria, cystitis, pyelonephritis and urosepsis with risk fac-
tors of neurogenic bladder [12] and prior UTI [8] having
been described. GBS is cultured from urine in approxi-
mately 2% of all clinically suspected cases of UTI
[6,8,13]. Particularly high prevalence rates of GBS bac-
teriuria have been reported among elderly adults
[1,14,15]. Here, we report the first case of an adult pa-
tient with an unusual, massive GBS abdominopelvic ab-
scess that occurred secondary to cystitis, and we review
prior cases of secondary GBS abscesses to describe their
etiology and clinical characteristics.Case presentation
A 46-year-old African-American woman presented to
the University Emergency Department complaining of
severe abdominal pain. On presentation, she reported
experiencing dysuria, urinary frequency and urgency, as
well as incontinence and abdominal fullness for several
weeks. Her medical history was unremarkable with no
history of sexually transmitted diseases and no current
medications. Her heart rate was 98, blood pressure
124/59mmHg, and her temperature was 37.6°C. Phys-
ical examination revealed increased tenderness in her
right and left lower quadrants. Urine analysis revealed
proteinuria, hematuria, pyuria (>50 white blood cells
per high-power field), and positive urinary leukocyte es-
terase. A culture of the patient’s urine, which was tur-
bid, yielded pure growth of S. agalactiae at 108 colony
forming units per liter. The patient had a hematocrit of
17%, a white blood cell count of 15.4 × 109/L, glucose
of 816mg/100mL, serum creatinine of 1.2mg/100mL,
and HbA1C of 10.6.A transvaginal ultrasound revealed a fibroid uterus
and a heterogeneous fluid collection in the patient’s pel-
vis. Examination by computed tomography (CT) showed
a massive peripherally enhancing, low-attenuating fluid
collection measuring approximately 17.4cm by 10.4cm
within her pelvis extending to the right adnexa (Figure 1).
A second smaller collection was noted within the pouch
of Douglas; the two fluid collections did not appear to
communicate. There were several reactive inguinal, mes-
enteric, and retroperitoneal lymph nodes as well as sub-
tle areas of right renal cortical non-enhancement
suggestive of pyelonephritis. The bladder wall was mark-
edly thickened with surrounding soft tissue stranding.
The patient was given one dose of ceftriaxone empiric-
ally. Her antibiotic regimen was then changed to vanco-
mycin and piperacillin/tazobactam for broad empiric
coverage and she was admitted for management of her
abdominopelvic abscess and UTI. She was also newly
diagnosed with diabetes and placed on sliding scale insu-
lin to manage her hyperglycemia. Her anemia was attrib-
uted to iron deficiency due to uterine leiomyomas.
A pigtail drainage catheter was placed using ultrasound
and fluoroscopic guidance in order to drain the patient’s
abdominopelvic abscess and this yielded a septic aspirate
that was culture positive for abundant S. agalactiae.
Antibiotic-susceptibility testing showed the isolate was re-
sistant to tetracycline, intermediate to clindamycin and
erythromycin, and sensitive to penicillin and vancomycin.
A day after abscess drainage, a CT scan showed near
complete interval resolution of the large pelvic fluid collec-
tion (Figure 1). The patient subsequently developed acute
kidney insufficiency (creatinine 5.0mg/100mL), leucocyt-
osis, and fever. Bacteremia was suspected, however, blood
cultures taken at this time were negative. Urine analysis
revealed persistent cystitis with pyuria and leukocyte ester-
ase. Her renal failure was attributed to multifactorial acute
tubular necrosis due to sepsis and vancomycin toxicity.
After 4 days of vancomycin and piperacillin/tazobactam,
the patient was switched to intravenous ceftriaxone (2g
intravenous/24 hours) and 2 days later her fever and ab-
dominal pain were resolved. The results of a repeat urine
test were culture-negative. The patient was discharged on
outpatient intravenous ceftriaxone and the pelvic drain
was removed 2 weeks later. Metformin and insulin glar-
gine treatment was commenced for diabetes management.
She remained afebrile and was well on subsequent out-
patient visits. Her acute kidney insufficiency resolved
within 7 days of discharge (creatinine 1.5mg/100mL). An
outpatient hysterectomy was planned for management of
the patient’s anemia due to uterine leiomyomas.
Discussion
GBS is a recognized cause of fatal puerperal sepsis in
adults and rare invasive infections including unusual
Figure 1 Computed tomography scans showing a large abscess within the patient’s pelvis that was culture positive for S. agalactiae.
Transverse (A) and coronal (B) contrast-enhanced computed tomography scans of the patient showing a large abscess within her pelvis
extending to the right adnexa (arrow) that was culture positive for S. agalactiae. Near complete resolution was achieved (C) one day after
fluoroscopic-guided abscess drainage.
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Sporadic cases of non-abdominopelvic secondary GBS
abscesses in adults have been reported in the litera-
ture; a review using the PubMed database (from 1966
to current; English) with the terms “group B strepto-
coccus,” and “Streptococcus agalactiae,” and “abscess”
identified 60 cases comprising subcutaneous (23),
retroperitoneal psoas (9), thoracic-aortic-myocardial
(9), epidural (7), renal (3), subphrenic (2), perinephric
(2), tubo-ovarian (2), suprasternal (1), adrenal (1), and
prostatic (1) abscesses (number of cases in paren-
theses). Diabetes is recognized in many of these cases
and probably represents a predisposing factor for inva-
sive disease. Mortality is rarely reported and in almost
all cases the etiology is unclear. In this case, UTI
appeared to be the underlying cause of the atypical
abscess in a patient who had no apparent risk factors
aside from the unrecognized diabetes. There was no
evidence of bladder perforation and management in-
cluding abscess drainage was successful.
This case is of interest for several reasons: first, most
intra-abdominal abscesses are polymicrobial in nature,
and secondary abscesses are a rare form of invasive GBS
infection in adults. Second, although cases of secondary
bacterial abscess have been associated with bacteremia,
primary suppuration, and sources of occult infection, no
prior case reports have associated an abdominopelvic ab-
scess with a preceding acute UTI. Although the cause ofthe abdominopelvic abscess in this case is most probably
the patient’s UTI, an unidentified gynecologic infection,
or potentially undetected bacteremia related to urosep-
sis, are also possible. There was no evidence of diverticu-
litis or bladder diverticula. Other etiologies of secondary
abscess include appendicitis, ulcerative colitis, osteomye-
litis, neoplasm, discitis, and trauma, none of which were
noted in this patient. A limitation of the present study
was that the GBS isolate cultured from the abdomino-
pelvic abscess fluid was not retained after the diagnosis.
Thus, a comparative molecular analysis, which is useful
as a tool for identifying clonal relationships between
GBS and could have defined the degree of relatedness of
the two isolates cultured from the patient in this case,
was not possible. In this regard, it is important to under-
score the fact that we were unable to confirm with cer-
tainty the possibility that the UTI was the primary
source of the abdominopelvic abscess in this patient.
Several recent reports have identified aspects of the
pathogenesis of acute UTI mediated by GBS [16-18], al-
though there is no experimental evidence reported in
the literature to the best of our knowledge that has asso-
ciated GBS cystitis with a secondary abscess.
Finally, the antibiotic susceptibility profile of an inter-
mediate phenotype for clindamycin and erythromycin
noted in this case is atypical for GBS. GBS is sensitive to
penicillin and its derivatives although it may be resistant
to antibiotics used for empiric treatment of UTI such as
Ulett et al. Journal of Medical Case Reports 2012, 6:237 Page 4 of 4
http://www.jmedicalcasereports.com/content/6/1/237trimethoprim-sulfamethoxazole. This illustrates the need
for careful consideration of the antibiotics that are used
empirically when GBS is cultured from suspected UTI.
Conclusions
This case defines a new disease etiology associated with
acute streptococcal cystitis and it will be of interest for
cases of UTI associated with abdominal and/or pelvic
pain. Overall, GBS is a relevant cause of secondary ab-
scess of various etiologies in adults, particularly those
with underlying medical problems. The particular eti-
ology of pyogenic abscess guides clinical management
and it is important to treat patients with antibiotics ac-
tive against GBS when this organism is found to be the
cause of a secondary abscess.
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